Ravi Rajagopalan

Executive Director, Drug Discovery at Blade Therapeutics

Ravi Rajagopalan's Professional Contact Details

Email (Verified)

****@blademed.com

Get Email Address

(650) 278-4291

Location

San Francisco, California, US

Company

Blade Therapeutics

Person Seniority

director

Ravi Rajagopalan's Current Company Details

Blade Therapeutics

South San Francisco, California, US • 12 Employees

pharmaceuticals

Blade Therapeutics is a private biopharmaceutical company revolutionizing the treatment of fibrotic disease. Fibrosis, a pathologic process in which progressive scarring replaces functional tissue, drives the progression of several debilitating diseases. Uncontrolled, progressive fibrosis leads to organ dysfunction and failure, and potentially death. In the U.S., many millions of Americans are afflicted with a fibrosis-related disease, which may affect organs including the kidney, liver, lungs, skin, and eye. Blade has assembled scientific and leadership teams withÂ unparalleled experience. Our scientific team as well as our Board have extensive expertise in fibrosis and the discovery and development of anti-fibrotic drugs. Blade's scientific advisory board includes world renowned experts in the pathobiology of fibrotic disease. By targeting novel pathways common to multiple fibrotic disease states, we believe we can build the leading company in anti-fibroticÂ drug discovery and development.

Founded Year

2015

Organization Website

blademed.com

Organization Revenue

7000

Current Technologies

outlook

apache

google analytics

mobile friendly

wordpress org